UNSPSC 85408601: Diagnosis of karyotype 45,x

This classification denotes the group of activities that yields a diagnosis of Karyotype 45,X. Karyotype 45,X is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code Q96. 0

UNSPSC 85408601 Diagnosis of karyotype 45,x is a Commodity code that shows minimal recent state and local procurement activity directly aligned with its nominal scope. The three recent opportunities tagged under this code involve diagnostic imaging systems (San Mateo Medical Center's PACS implementation), ultrasound equipment (Collier County's single-source procurement of the KOSMOS platform), and phlebotomy services (Albuquerque Police Department's blood draw services). None of these solicitations directly addresses karyotype diagnosis or genetic testing; the code appears to be a misclassification across diverse health-related services and equipment purchases. Issuing bodies include a county public hospital system, a county government procurement division, and a city police department—spanning clinical infrastructure, mobile diagnostics, and forensic laboratory support functions. The geographic spread is limited to California, Florida, and New Mexico based on recent activity.

Recent opportunities show no competitive bidding activity specific to karyotype diagnosis services. San Mateo Medical Center (San Mateo County, California) posted an RFP on July 9, 2026, with an August 7, 2026 response deadline for a diagnostic imaging PACS with EPIC integration and 99.9% uptime requirements; Collier County, Florida issued a Notice of Intent to Single Source EchoNous, Inc. for ultrasound equipment, with a March 26, 2026 deadline; and the Albuquerque Police Department issued an RFB on January 26, 2026, with a February 25, 2026 deadline for on-call phlebotomy technicians serving Bernalillo County. The misalignment between the code's stated scope and the actual solicitations suggests that this code is not a reliable procurement vehicle for genetic or cytogenetic testing services in state and local markets.